Search for Clinical Trial Results
Merkel Cell Carcinoma - 28 Studies Found
Status | Study |
Recruiting |
Study Name: QUILT-3.009: Study of aNK Infusions in Combination With ALT-803 in Patients With Stage III (IIIB) or Stage (IV) Merkel Cell Carcinoma (MCC) Condition:
|
Active, not recruiting |
Study Name: Merkel Positron Emission Tomography (PET) Protocol Condition: Merkel Cell Carcinoma Date: 2009-11-12 Interventions:
|
Recruiting |
Study Name: Avelumab in Subjects With Merkel Cell Carcinoma (JAVELIN Merkel 200) Condition: Carcinoma, Merkel Cell Date: 2014-06-02 Interventions: Drug: Avelumab Avelumab will be administered at a dose of 10 milligram per kilogram (mg/kg) as 1-hour in |
Recruiting |
Study Name: Randomized Study of Nivolumab+Ipilimumab+/- SBRT for Metastatic Merkel Cell Carcinoma Condition:
Date: 2017-03-01 Interventions:
|
Recruiting |
Study Name: Localized Radiation Therapy or Recombinant Interferon Beta and Avelumab With or Without Cellular Adoptive Immunotherapy in Treating Patients With Metastatic Merkel Cell Carcinoma Condition:
|
Completed |
Study Name: S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer Condition: Neuroendocrine Carcinoma of the Skin Date: 1999-11-01 Interventions:
|
Recruiting |
Study Name: A Study of T-VEC (Talimogene Laherparepvec) With or Without Radiotherapy for Melanoma, Merkel Cell Carcinoma, or Other Solid Tumors Condition:
|
Active, not recruiting |
Study Name: Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer Condition:
|
Recruiting |
Study Name: Treatment of Unresecable and/or Metastatic Merkel Cell Carcinoma by Somatostatine Analogues Condition: Carcinoma, Merkel Cell Date: 2015-01-13 Interventions: Drug: Lanreotide Other Name: Somatuline |
Completed |
Study Name: S0331: Imatinib Mesylate in Treating Patients With Metastatic or Unresectable Merkel Cell Cancer Condition:
|